[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=1779968 [NCBI, ExPASy, EBI, Israel, Japan]
Iacangelo A.L.,
Grimes M.,
Eiden L.E.;
"The bovine chromogranin A gene: structural basis for hormone regulation and generation of biologically active peptides.";
Mol. Endocrinol. 5:1651-1660(1991).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=3755681 [NCBI, ExPASy, EBI, Israel, Japan]
Benedum U.M.,
Baeuerle P.A.,
Konecki D.S.,
Frank R.,
Powell J.,
Mallet J.,
Huttner W.B.;
"The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells.";
EMBO J. 5:1495-1502(1986).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1038/323082a0; PubMed=3018587 [NCBI, ExPASy, EBI, Israel, Japan]
Iacangelo A.L.,
Affolter H.-U.,
Eiden L.E.,
Herbert E.,
Grimes M.;
"Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues.";
Nature 323:82-86(1986).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=3474638 [NCBI, ExPASy, EBI, Israel, Japan]
Ahn T.G.,
Cohn D.V.,
Gorr S.U.,
Ornstein D.L.,
Kashdan M.A.,
Levine M.A.;
"Primary structure of bovine pituitary secretory protein I (chromogranin A) deduced from the cDNA sequence.";
Proc. Natl. Acad. Sci. U.S.A. 84:5043-5047(1987).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1016/S0014-5793(97)00099-9; PubMed=9074643 [NCBI, ExPASy, EBI, Israel, Japan]
Kang Y.K.,
Yoo S.H.;
"Identification of the secretory vesicle membrane binding region of chromogranin A.";
FEBS Lett. 404:87-90(1997).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=Hereford;
TISSUE=Ascending colon;
NIH - Mammalian Gene Collection (MGC) project;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
|
[7]
|
PROTEIN SEQUENCE OF 19-28; 97-106; 134-143; 266-275 AND 350-359, AND MASS SPECTROMETRY.
TISSUE=Chromaffin cell;
DOI=10.1021/bi0300433; PubMed=12795588 [NCBI, ExPASy, EBI, Israel, Japan]
Lee J.C.,
Taylor C.V.,
Gaucher S.P.,
Toneff T.,
Taupenot L.,
Yasothornsrikul S.,
Mahata S.K.,
Sei C.,
Parmer R.J.,
Neveu J.M.,
Lane W.S.,
Gibson B.W.,
O'Connor D.T.,
Hook V.Y.H.;
"Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin A into active catestatin secreted from neuroendocrine chromaffin cells.";
Biochemistry 42:6938-6946(2003).
|
[8]
|
PROTEIN SEQUENCE OF 19-38; 97-111 AND 134-139.
PubMed=1986917 [NCBI, ExPASy, EBI, Israel, Japan]
Barbosa J.A.,
Gill B.M.,
Takiyyuddin M.A.,
O'Connor D.T.;
"Chromogranin A: posttranslational modifications in secretory granules.";
Endocrinology 128:174-190(1991).
|
[9]
|
PROTEIN SEQUENCE OF 19-45, AND CALCIUM-BINDING.
PubMed=2387861 [NCBI, ExPASy, EBI, Israel, Japan]
Yoo S.H.,
Albanesi J.P.;
"Ca2(+)-induced conformational change and aggregation of chromogranin A.";
J. Biol. Chem. 265:14414-14421(1990).
|
[10]
|
PROTEIN SEQUENCE OF 19-26 AND 266-272.
DOI=10.1016/0014-5793(93)80715-7; PubMed=8243650 [NCBI, ExPASy, EBI, Israel, Japan]
Yoo S.H.,
Ferretti J.A.;
"Nature of the pH-induced conformational changes and exposure of the C-terminal region of chromogranin A.";
FEBS Lett. 334:373-377(1993).
|
[11]
|
PROTEIN SEQUENCE OF 142-161, AND SYNTHESIS OF CHROMOSTATIN.
PubMed=1996343 [NCBI, ExPASy, EBI, Israel, Japan]
Galindo E.,
Rill A.,
Bader M.-F.,
Aunis D.;
"Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion.";
Proc. Natl. Acad. Sci. U.S.A. 88:1426-1430(1991).
|
[12]
|
ERRATUM.
Galindo E.,
Rill A.,
Bader M.-F.,
Aunis D.;
Proc. Natl. Acad. Sci. U.S.A. 91:832-832(1994).
|
[13]
|
PROTEIN SEQUENCE OF 266-331.
PubMed=1710890 [NCBI, ExPASy, EBI, Israel, Japan]
Watkinson A.,
Jonsson A.C.,
Davison M.,
Young J.,
Lee C.M.,
Moore S.,
Dockray G.J.;
"Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.";
Biochem. J. 276:471-479(1991).
|
[14]
|
PROTEIN SEQUENCE OF 266-312.
DOI=10.1016/0167-0115(89)90262-0; PubMed=2756155 [NCBI, ExPASy, EBI, Israel, Japan]
Nakano I.,
Funakoshi A.,
Miyasaka K.,
Ishida K.,
Makk G.,
Angwin P.,
Chang D.,
Tatemoto K.;
"Isolation and characterization of bovine pancreastatin.";
Regul. Pept. 25:207-213(1989).
|
[15]
|
PROTEIN SEQUENCE OF 303-331.
PubMed=8240272 [NCBI, ExPASy, EBI, Israel, Japan]
Watkinson A.,
Rogers M.,
Dockray G.J.;
"Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum.";
Biochem. J. 295:649-654(1993).
|
[16]
|
PROTEIN SEQUENCE OF 191-212 (CHROMACIN), PHOSPHORYLATION AT TYR-191, AND GLYCOSYLATION AT SER-204.
TISSUE=Chromaffin cell;
DOI=10.1074/jbc.271.45.28533; PubMed=8910482 [NCBI, ExPASy, EBI, Israel, Japan]
Strub J.-M.,
Goumon Y.,
Lugardon K.,
Capon C.,
Lopez M.,
Moniatte M.,
van Dorsselaer A.,
Aunis D.,
Metz-Boutigue M.-H.;
"Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules.";
J. Biol. Chem. 271:28533-28540(1996).
|
[17]
|
CHARACTERIZATION OF CATESTATIN.
PubMed=9294131 [NCBI, ExPASy, EBI, Israel, Japan]
Mahata S.K.,
O'Connor D.T.,
Mahata M.,
Yoo S.H.,
Taupenot L.,
Wu H.,
Gill B.M.,
Parmer R.J.;
"Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.";
J. Clin. Invest. 100:1623-1633(1997).
|
[18]
|
CHARACTERIZATION OF CATESTATIN.
DOI=10.1016/S0196-9781(98)00086-2; PubMed=9786174 [NCBI, ExPASy, EBI, Israel, Japan]
Kennedy B.P.,
Mahata S.K.,
O'Connor D.T.,
Ziegler M.G.;
"Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.";
Peptides 19:1241-1248(1998).
|
[19]
|
CHARACTERIZATION OF VASOSTATIN-1.
DOI=10.1074/jbc.275.15.10745; PubMed=10753865 [NCBI, ExPASy, EBI, Israel, Japan]
Lugardon K.,
Raffner R.,
Goumon Y.,
Corti A.,
Delmas A.,
Bulet P.,
Aunis D.,
Metz-Boutigue M.-H.;
"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.";
J. Biol. Chem. 275:10745-10753(2000).
|
[20]
|
GLYCOSYLATION AT SER-185 AND THR-249, PHOSPHORYLATION, AND DISULFIDE BOND.
DOI=10.1006/abio.1999.4244; PubMed=10527498 [NCBI, ExPASy, EBI, Israel, Japan]
Bauer S.H.,
Zhang X.Y.,
Van Dongen W.,
Claeys M.,
Przybylski M.;
"Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry.";
Anal. Biochem. 274:69-80(1999).
|
[21]
|
3D-STRUCTURE MODELING OF CATESTATIN.
DOI=10.1016/S0167-0115(98)00040-8; PubMed=9809795 [NCBI, ExPASy, EBI, Israel, Japan]
Tsigelny I.,
Mahata S.K.,
Taupenot L.,
Preece N.E.,
Mahata M.,
Khan I.,
Parmer R.J.,
O'Connor D.T.;
"Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.";
Regul. Pept. 77:43-53(1998).
|
[22]
|
STRUCTURE BY NMR OF 368-380.
DOI=10.1016/j.regpep.2003.10.035; PubMed=14759560 [NCBI, ExPASy, EBI, Israel, Japan]
Preece N.E.,
Nguyen M.,
Mahata M.,
Mahata S.K.,
Mahapatra N.R.,
Tsigelny I.,
O'Connor D.T.;
"Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.";
Regul. Pept. 118:75-87(2004).
|
|
ExPASy Home page
SIB Switzerland
